Patents for A61K 49 - Preparations for testing in vivo (35,376)
03/2005
03/23/2005EP1516623A1 Drug for prevention and/or treatment of constipation and symptom caused by constipation
03/23/2005EP1516185A2 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor
03/23/2005EP0877630B1 Contrast media
03/23/2005CN1599577A Peptide-based multimeric targeted contrast agents
03/23/2005CN1193793C Diarylprophin photosensitizer and its preparing process and usage
03/22/2005US6869939 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
03/22/2005US6869802 Combined cholesterol and bilirubin tests as risk predictors for coronary artery disease
03/22/2005US6869772 Method for labeling individual cells
03/22/2005US6869768 Determination genotypes
03/22/2005US6869593 Diagnosis of anticholesterol agents; cardiovascular disorders; in situ detection of apatite
03/22/2005US6869592 Method and antibody for imaging lung cancer
03/22/2005US6869591 Paramagnetic particles that provide improved relaxivity
03/22/2005US6869590 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
03/22/2005US6869545 Colloidal nanocrystals with high photoluminescence quantum yields and methods of preparing the same
03/17/2005WO2005024442A2 Nanoparticulate probe for in vivo monitoring of tissue oxygenation
03/17/2005WO2005024417A1 A simple apparatus for preparing experimental models of brain neuronal damage and preparation of secondary brain damage model with methods for evaluation of drug efficacy of novel compounds against brain damage and memory-related events
03/17/2005WO2005023314A1 Compounds containing matrix metalloproteinase substrates and methods of their use
03/17/2005WO2005023180A2 Method for detecting cancer cells and monitoring cancer therapy
03/17/2005WO2005023096A2 Methods and compositions for ultrasound imaging of apoptosis
03/17/2005WO2004091396A3 Method for the spatially resolved determination of physical, chemical and/or biological properties or state variables
03/17/2005WO2004091394A3 Method to determine the spatial distribution of magnetic particles and magnetic particle administering compositions
03/17/2005WO2004091386A3 Arrangement and method for the spatially resolved determination of state variables in an examination area
03/17/2005WO2004025259A3 Site-specific labeling of affinity tags in fusion proteins
03/17/2005WO2003101484A9 Compositions and methods for transepithelial molecular transport
03/17/2005US20050059977 Monitoring circadian activity
03/17/2005US20050059888 Biopsy cavity marking device and method
03/17/2005US20050059881 Method for enhancing contrast produced by MRI
03/17/2005US20050059592 EphA2 and hyperproliferative cell disorders
03/17/2005US20050059080 Absorbable sponge with contrasting agent
03/17/2005US20050058661 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus Borrelia
03/17/2005US20050058605 gas or air filled microballoons in aqueous suspension; imaging contrast agent; ultrasonic echography
03/17/2005US20050058604 Phthalamide-lanthanide complexes for use as luminescent markers
03/17/2005US20050058603 Biocompatible polymeric shell around hollow core; containing magnetic resonance imaging contrast agents
03/17/2005US20050058602 Using mixture of blue dye, red dye, yellow dye solvent and flavor; applying defects; detecting defects; colorimetric analysis
03/17/2005US20050058601 Polypodal chelants for metallopharmaceuticals
03/17/2005US20050058600 Administering; dosage; detection response; benign prostate hyperplasia; acne
03/17/2005US20050058599 Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent
03/17/2005US20050058598 Method and apparatus for quantitatively evaluating a kidney
03/17/2005DE10339820A1 Use of G-protein coupled receptor, GPR49, peptides, protein and nucleic acid, for diagnosis and prognosis of tumors, also in screening for therapeutic and diagnostic agents
03/17/2005CA2577909A1 Polarizing agents for dynamic nuclear polarization
03/17/2005CA2541385A1 Nanoparticulate probe for in vivo monitoring of tissue oxygenation
03/17/2005CA2537771A1 Compounds containing matrix metalloproteinase substrates and methods of their use
03/17/2005CA2535770A1 Method for detecting cancer cells and monitoring cancer therapy
03/16/2005EP1514934A2 Biosynthetic binding protein for cancer marker
03/16/2005EP1514117A1 Methods for avoiding renal injury
03/16/2005EP1513450A1 Method of preparing gas-filled polymer matrix microparticles useful for echographic imaging
03/16/2005EP1112254A4 Cyanine dyes and synthesis methods thereof
03/16/2005EP0721783B1 Preventive and remedy for diseases caused by fibrinoid or thrombus formation in the lung
03/15/2005US6866873 Nutritional dietary system, formulation, kit and method for use in preparing an individual for a predetermined activity
03/10/2005WO2005021556A2 Modified protease inhibitors
03/10/2005WO2005021538A1 Novel chelating agents and chelates and their use
03/10/2005WO2005021501A1 Minimally invasive physiological function monitoring agents
03/10/2005WO2005021494A2 D-amino acid peptides
03/10/2005WO2005020918A2 Ultrasonic concentration of drug delivery capsules
03/10/2005WO2005020905A2 Echogenic coatings with overcoat
03/10/2005WO2005004992A3 Magnetic resonance contrast-enhancing agents and method for detecting and imaging artherosclerotic plaque
03/10/2005WO2005000109A3 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
03/10/2005WO2004110963A3 Glycerophosphocholine and its derivatives for medical imaging neuropsychiatric disorders
03/10/2005WO2004087888A3 Neurotransmitter signaling can regulate life span in c. elegans
03/10/2005WO2004081031A3 Thiol-mediated drug attachment to targeting peptides
03/10/2005WO2004044557A3 Non-invasive measurement of analytes
03/10/2005US20050053945 Nucleosides; bioconjugation; solid phase synthesis
03/10/2005US20050053675 Method of making, and the use of cytotoxic agents containing elemental selenium
03/10/2005US20050053637 Designing an individual's skin care protocol based on a biomarker profile determined from sampled skin; skin condition such as atopic, psoriasis, seborrhea, ichtiotic, acne, xerotic, irritation, allergy
03/10/2005US20050053552 Phase shift colloids as ultrasound contrast agents
03/10/2005US20050053551 Graphic visualization for angiography, computed axial tomography, intravenous urography, cholangiography, and CT scans; increasing radiographic density of gadolinium contrast while minimizing iodinated contrast; side effect reduction
03/10/2005US20050053550 Spatial evolution of neural activity
03/10/2005US20050053549 Method for treating airway disorders
03/10/2005US20050051179 Simple apparatus for preparing experimental models of brain neuronal damage and preparation of secondary brain damage model with methods for evaluation of drug efficacy of novel compounds against brain damage and memory-related events
03/10/2005CA2537113A1 Modified protease inhibitors
03/10/2005CA2536947A1 Echogenic coatings
03/10/2005CA2536783A1 Novel chelating agents and chelates and their use
03/10/2005CA2529027A1 D-amino acid peptides
03/09/2005EP1511851A2 Method for identification of biologically active agents
03/09/2005EP1511518A2 Neutrophil imaging methods in cystic fibrosis
03/09/2005EP1511476A2 Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same
03/09/2005EP1511425A1 Temporary tattoo for testing the sensitivity of skin to chemicals
03/09/2005EP1511379A1 Prevention or treatment of abnormal lipoprotein, cholestasis and atherosclerosis
03/09/2005EP1511376A2 Transgenic zebrafish models for thrombosis
03/09/2005EP1003501B1 Use of an agent for lowering the risk of cardiovascular disease
03/09/2005CN1592748A Separation of regioisomers of metal phthalocyanines
03/09/2005CN1191822C Prepn .of lipid blend and phospholipid suspension contg. the lipid blend
03/08/2005US6864227 Artery-and vein-specific proteins and uses therefor
03/08/2005US6864103 Such as hydroxyisophthamidylamide-based bidentate ligands; bioavailiable probes for use in immunoassay
03/08/2005US6863211 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application
03/08/2005CA2190134C Continuous method of grinding pharmaceutical substances
03/03/2005WO2005019252A2 Novel fluorescent and colored proteins, and polynucleotides that encode these proteins
03/03/2005WO2005019247A2 Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy
03/03/2005WO2005018680A1 Target-specific activatable polymeric imaging agents
03/03/2005WO2005018667A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
03/03/2005WO2005018341A1 Food for testing life style-related diseases
03/03/2005WO2005018316A1 Hypertrophic cardiomyopathy model animal
03/03/2005WO2005000218A3 Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical applications
03/03/2005WO2004092404A3 Inhibitors of acidic mammalian chitinase as asthma therapeutics
03/03/2005WO2004092325A3 Screening methods using zebrafish to identify thrombotic and anti-thrombotic compounds and genes
03/03/2005WO2004073640A3 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
03/03/2005WO2004062627A3 In vivo screening models for treatment of alzheimer's disease and other neurodegenerative disorders
03/03/2005WO2004009134A8 Procedures of cellular labelling with paramagnetic complexes for mri applications
03/03/2005US20050049507 Method and measuring changes in microvascular capillary blood flow
03/03/2005US20050049484 Methods and apparatus for monitoring and quantifying the movement of fluid